Skip To The Main Content

New Decade, New Focus for PDA Letter

The PDA Letter began the new decade with a focused on publishing all content to the website first. 

Rebecca Stauffer

You have probably seen more content on the site lately. As indicated in my previous message, we are publishing more content each week on the site. From articles to videos to even our long-awaited and anticipated PDA podcast, we are delivering more to our readers who are hungry for the latest information to help them in their jobs within the pharmaceutical manufacturing community.

Print issues will now collect popular articles already published on the Letter website. The January/February issue includes content covering critical topics of interest such as a new USP chapter and its impact on closed system transfer devices, building up a product quality leader team and a potential U.S. EPA regulatory change that could affect medical device sterilization.

In addition, we are preparing for the first regional edition of the PDA Letter that will feature content of interest for our European readers. An Asia-Pacific-focused one will then follow.

But I could not have done these changes alone. In addition to the hard work of the other PDA publishing staff—Katja Yount, Walter Morris and Marilyn Foster—the members of the PDA Letter Editorial Committee have been of great assistance in reviewing articles. With this in mind, I would like to welcome the following new members to the Editorial Committee this year, some of whom are also assisting with the regional editions: Claire Briglia, Subrata Chakraborty, Robert Guidos, David Hubmayr, Jason Kerr, Ivy Louis, Pierre Rousseau, Siegfried Schmitt and Raji Vathyam.

I would also like to thank those Committee members coming off their terms as of the end of 2019: Joanne Beck, Stephanie Gaulding and Richard Hameister.

As the Letter offers more weekly content, I would encourage you, if you have not already, to consider writing an article. I would be more than happy to help and share our Author Guidelines. Email me or send me a message via my Twitter or LinkedIn account.